Unilife: Here’s What Investors Need to Know Before Earnings

Unilife (NASDAQ:UNIS) will report earnings after markets close on Thursday, May 9th. Unilife Corporation designs and manufactures medical devices. The Company produces retractable syringes. Unilife markets its products to pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities, and patients who self-administer prescription medication.

Here is your Cheat Sheet to Unilife Earnings:

Earnings Expectations: Analysts expect earnings of $-0.14 per share on revenues of $2.61 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.08 to a loss $0.1. For the current year, the average estimate is a loss of $0.57, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Unilife has been performing on an annual basis:

Fiscal Year 2009 2010 2011 2012
Revenue ($) in millions 19.98 11.42 6.65 5.52
Diluted EPS ($) -0.02 -0.64 -0.70 -0.78

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 0.91 1.25 1.23 0.69 0.70
Diluted EPS ($) -0.19 -0.21 -0.2093 -0.16 -0.19

Past Performance:
Unilife has missed analyst estimates 3 times in the past four quarters. Shareholders could expect a bust if the company misses estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)